Neuronal plasticity and its role in Alzheimer's disease and Parkinson's disease.
Level 5 - mechanism / opinion, no new human data
Qualitative systematic review synthesizing mechanistic and preclinical concepts without clinical trial meta-analysis
PubMed 39688547 · doi:10.4103/NRR.NRR-D-24-01019
What was done
A systematic literature review was conducted across databases including PubMed, Scopus, and Google Scholar to examine the mechanisms of neuronal plasticity and potential therapeutic approaches in Alzheimer's disease and Parkinson's disease. The authors synthesized themes spanning synaptic mechanisms, neurogenesis, molecular tools, and clinical interventions.
What was found
The abstract reports no numerical findings, effect sizes, or statistical metrics. It describes qualitative findings that amyloid-beta plaques and tau tangles impair synaptic function in Alzheimer's disease, while loss of dopaminergic neurons drives Parkinson's disease deficits. Targeting plasticity mechanisms such as long-term potentiation and long-term depression, alongside neurotrophic factors, CRISPR, optogenetics, dopamine replacement, deep brain stimulation, and lifestyle interventions, are identified as potential therapeutic avenues.
Why it matters
This paper summarizes conceptual frameworks linking basic synaptic plasticity mechanisms to potential multidisciplinary treatment strategies for major neurodegenerative disorders.
Limits
The abstract does not disclose the number of studies reviewed, specific selection criteria, risk of bias evaluation, or quantitative synthesis. The findings represent narrative-style mechanistic overviews rather than primary empirical or trial data.
Cited by
- contradicts There are only two mechanisms by which the brain rewires itself: through intense experience and through repetition.